🇺🇸 FDA
Patent

US 9993660

Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections

granted A61KA61K41/0052A61K45/06

Quick answer

US patent 9993660 (Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections) held by The United States of America as represented by the Secretary of Navy expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of Navy
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K41/0052, A61K45/06, A61K47/6835, A61K47/6923